Share Price and Basic Stock Data
Last Updated: October 8, 2025, 11:40 pm
| PEG Ratio | -121.17 |
|---|
Analyst Insight & Comprehensive Analysis
Balgopal Commercial Ltd, a Trading & Distributors company, currently trades at ₹243 with a market capitalization of ₹462 Cr. The company’s Price-to-Earnings ratio stands at a high 112, indicating potentially overvalued stock compared to sector averages in India, where the typical P/E ratio hovers around 20-30. Despite this, Balgopal shows a respectable Return on Equity (ROE) of 12.6% and Return on Capital Employed (ROCE) of 14.8%, suggesting efficient utilization of capital. With zero borrowings and a healthy reserve of ₹37.65 Cr, the company displays strong financial discipline and resilience.
One key strength of Balgopal is its low debt levels and solid financial position, providing stability and flexibility for future growth opportunities. However, the high P/E ratio may deter value investors looking for more reasonably priced stocks. The lack of institutional ownership from FIIs and DIIs could also pose a risk in terms of market interest and liquidity. Looking ahead, diversifying the shareholder base and improving operational efficiency could enhance the company’s competitiveness and appeal to a wider investor audience.
In conclusion, while Balgopal Commercial Ltd exhibits sound financial health and operational efficiency, investors should carefully assess the premium valuation and limited institutional interest. Monitoring how the company addresses these factors will be crucial in determining its long-term performance and investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Balgopal Commercial Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minal Industries Ltd | 76.2 Cr. | 3.97 | 5.59/3.20 | 45.4 | 2.77 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Mitshi India Ltd | 13.5 Cr. | 15.4 | 19.5/13.0 | 451 | 3.09 | 0.00 % | 0.36 % | 0.37 % | 10.0 |
| Modella Woollens Ltd | 6.01 Cr. | 66.0 | 74.2/52.5 | 3.63 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 76.0 Cr. | 37.1 | 44.4/10.2 | 75.2 | 15.0 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| MRP Agro Ltd | 108 Cr. | 97.5 | 174/84.4 | 14.6 | 29.3 | 0.00 % | 39.2 % | 30.3 % | 10.0 |
| Industry Average | 11,158.21 Cr | 168.53 | 103.57 | 113.41 | 0.25% | 15.73% | 9.23% | 7.74 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.17 | 3.93 | 2.01 | 1.08 | 1.00 | 6.03 | 8.92 | 1.09 | 0.05 | 0.33 | 0.18 | 0.00 | 0.00 |
| Expenses | 1.12 | 3.81 | 2.00 | 1.17 | 0.97 | 4.62 | 7.69 | 1.39 | 0.22 | 0.24 | 0.45 | 0.36 | 0.30 |
| Operating Profit | 0.05 | 0.12 | 0.01 | -0.09 | 0.03 | 1.41 | 1.23 | -0.30 | -0.17 | 0.09 | -0.27 | -0.36 | -0.30 |
| OPM % | 4.27% | 3.05% | 0.50% | -8.33% | 3.00% | 23.38% | 13.79% | -27.52% | -340.00% | 27.27% | -150.00% | ||
| Other Income | 0.04 | 1.84 | 1.87 | -3.81 | 2.07 | 2.74 | 2.74 | 4.23 | 4.69 | 7.93 | 0.17 | -4.65 | 2.34 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.09 | 1.96 | 1.88 | -3.90 | 2.10 | 4.15 | 3.97 | 3.93 | 4.52 | 8.02 | -0.10 | -5.01 | 2.04 |
| Tax % | -377.78% | 10.71% | 5.85% | -3.08% | 23.33% | 0.72% | 6.80% | 5.09% | 14.16% | 11.35% | 170.00% | -12.57% | 17.65% |
| Net Profit | 0.43 | 1.75 | 1.77 | -3.78 | 1.61 | 4.11 | 3.70 | 3.74 | 3.88 | 7.10 | -0.27 | -4.38 | 1.68 |
| EPS in Rs | 0.26 | 1.06 | 1.07 | -2.29 | 0.98 | 2.49 | 2.24 | 2.27 | 2.35 | 4.30 | -0.16 | -2.30 | 0.88 |
Last Updated: August 19, 2025, 10:45 pm
Below is a detailed analysis of the quarterly data for Balgopal Commercial Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 0.30 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.36 Cr. (Mar 2025) to 0.30 Cr., marking a decrease of 0.06 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.30 Cr.. The value appears strong and on an upward trend. It has increased from -0.36 Cr. (Mar 2025) to -0.30 Cr., marking an increase of 0.06 Cr..
- For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Other Income, as of Jun 2025, the value is 2.34 Cr.. The value appears strong and on an upward trend. It has increased from -4.65 Cr. (Mar 2025) to 2.34 Cr., marking an increase of 6.99 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 2.04 Cr.. The value appears strong and on an upward trend. It has increased from -5.01 Cr. (Mar 2025) to 2.04 Cr., marking an increase of 7.05 Cr..
- For Tax %, as of Jun 2025, the value is 17.65%. The value appears to be increasing, which may not be favorable. It has increased from -12.57% (Mar 2025) to 17.65%, marking an increase of 30.22%.
- For Net Profit, as of Jun 2025, the value is 1.68 Cr.. The value appears strong and on an upward trend. It has increased from -4.38 Cr. (Mar 2025) to 1.68 Cr., marking an increase of 6.06 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.88. The value appears strong and on an upward trend. It has increased from -2.30 (Mar 2025) to 0.88, marking an increase of 3.18.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 2:40 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.81 | 3.81 | 2.60 | 4.57 | 14.80 | 16.40 | 9.61 | 5.36 | 8.00 | 8.19 | 17.05 | 0.56 |
| Expenses | 0.80 | 4.13 | 3.00 | 5.22 | 15.97 | 19.79 | 18.16 | 6.13 | 8.55 | 8.00 | 14.69 | 1.27 |
| Operating Profit | 0.01 | -0.32 | -0.40 | -0.65 | -1.17 | -3.39 | -8.55 | -0.77 | -0.55 | 0.19 | 2.36 | -0.71 |
| OPM % | 1.23% | -8.40% | -15.38% | -14.22% | -7.91% | -20.67% | -88.97% | -14.37% | -6.88% | 2.32% | 13.84% | -126.79% |
| Other Income | 0.00 | 0.40 | 0.45 | 0.70 | 0.82 | 1.29 | 1.57 | 7.52 | 0.92 | -0.05 | 11.79 | 8.14 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.01 | 0.08 | 0.05 | 0.05 | -0.35 | -2.10 | -6.98 | 6.75 | 0.37 | 0.04 | 14.15 | 7.43 |
| Tax % | 0.00% | 25.00% | 40.00% | 20.00% | -8.57% | 6.19% | -8.17% | 14.52% | 18.92% | -350.00% | 7.00% | 14.67% |
| Net Profit | 0.00 | 0.06 | 0.03 | 0.05 | -0.32 | -2.24 | -6.42 | 5.77 | 0.30 | 0.17 | 13.17 | 6.34 |
| EPS in Rs | 0.00 | 0.04 | 0.02 | 0.03 | -0.19 | -1.36 | -3.89 | 3.49 | 0.18 | 0.10 | 7.98 | 3.34 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 66.67% | -740.00% | -600.00% | -186.61% | 189.88% | -94.80% | -43.33% | 7647.06% | -51.86% |
| Change in YoY Net Profit Growth (%) | 0.00% | 116.67% | -806.67% | 140.00% | 413.39% | 376.48% | -284.68% | 51.47% | 7690.39% | -7698.92% |
Balgopal Commercial Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -17% |
| 5 Years: | -43% |
| 3 Years: | -59% |
| TTM: | -97% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 59% |
| 5 Years: | 24% |
| 3 Years: | 185% |
| TTM: | -73% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 137% |
| 1 Year: | 165% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 12% |
| 3 Years: | 10% |
| Last Year: | 15% |
Last Updated: September 5, 2025, 2:36 pm
Balance Sheet
Last Updated: October 10, 2025, 3:35 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.24 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 19.01 |
| Reserves | 17.75 | 1.54 | 1.57 | 1.61 | 1.29 | -0.95 | -7.36 | -1.59 | -1.27 | -1.10 | 12.07 | 37.65 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | 4.24 | 0.02 | 0.46 | 0.47 | 0.11 | 0.39 | 1.35 | 3.53 | 2.23 | 6.17 | 7.81 |
| Total Liabilities | 17.99 | 22.29 | 18.10 | 18.58 | 18.27 | 15.67 | 9.54 | 16.52 | 18.77 | 17.64 | 34.75 | 64.47 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 7.42 | 2.40 | 5.79 | 7.42 | 3.60 | 4.28 | 4.48 | 11.44 | 16.89 | 7.28 | 21.09 | 40.03 |
| Other Assets | 10.57 | 19.89 | 12.31 | 11.16 | 14.67 | 11.39 | 5.06 | 5.08 | 1.88 | 10.36 | 13.66 | 24.44 |
| Total Assets | 17.99 | 22.29 | 18.10 | 18.58 | 18.27 | 15.67 | 9.54 | 16.52 | 18.77 | 17.64 | 34.75 | 64.47 |
Below is a detailed analysis of the balance sheet data for Balgopal Commercial Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 19.01 Cr.. The value appears strong and on an upward trend. It has increased from 16.51 Cr. (Mar 2024) to 19.01 Cr., marking an increase of 2.50 Cr..
- For Reserves, as of Mar 2025, the value is 37.65 Cr.. The value appears strong and on an upward trend. It has increased from 12.07 Cr. (Mar 2024) to 37.65 Cr., marking an increase of 25.58 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 7.81 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.17 Cr. (Mar 2024) to 7.81 Cr., marking an increase of 1.64 Cr..
- For Total Liabilities, as of Mar 2025, the value is 64.47 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 34.75 Cr. (Mar 2024) to 64.47 Cr., marking an increase of 29.72 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 40.03 Cr.. The value appears strong and on an upward trend. It has increased from 21.09 Cr. (Mar 2024) to 40.03 Cr., marking an increase of 18.94 Cr..
- For Other Assets, as of Mar 2025, the value is 24.44 Cr.. The value appears strong and on an upward trend. It has increased from 13.66 Cr. (Mar 2024) to 24.44 Cr., marking an increase of 10.78 Cr..
- For Total Assets, as of Mar 2025, the value is 64.47 Cr.. The value appears strong and on an upward trend. It has increased from 34.75 Cr. (Mar 2024) to 64.47 Cr., marking an increase of 29.72 Cr..
Notably, the Reserves (37.65 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.01 | -0.32 | -0.40 | -0.65 | -1.17 | -3.39 | -8.55 | -1.02 | -0.55 | 0.19 | 2.36 | -0.71 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 365.00 | 233.75 | 4.21 | 112.61 | 195.57 | 107.94 | 109.01 | 121.89 | 15.06 | 25.85 | 0.00 | 0.00 |
| Inventory Days | 2,737.50 | 780.21 | 1,056.29 | 411.08 | 114.63 | 61.12 | 0.00 | 47.74 | 68.23 | 280.44 | 14.79 | |
| Days Payable | 0.00 | 407.49 | 0.00 | 32.92 | 11.15 | 0.00 | 46.27 | 97.68 | 88.38 | 0.00 | ||
| Cash Conversion Cycle | 3,102.50 | 606.48 | 1,060.50 | 490.78 | 299.04 | 169.06 | 109.01 | 123.36 | -14.39 | 217.90 | 14.79 | 0.00 |
| Working Capital Days | 4,763.02 | 1,491.61 | 1,715.50 | 852.20 | 349.22 | 251.94 | 158.76 | 264.90 | -53.84 | 365.45 | 160.34 | 6,537.41 |
| ROCE % | 0.06% | 0.44% | 0.28% | 0.28% | -1.11% | -12.59% | -56.50% | 55.51% | -1.97% | -16.64% | 17.50% | 14.81% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 15 | Mar 14 |
|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.70 | 0.04 | 0.12 |
| Diluted EPS (Rs.) | 3.52 | 0.04 | 0.12 |
| Cash EPS (Rs.) | 3.31 | 0.03 | 0.15 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 29.77 | 10.99 | 757.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 29.77 | 10.99 | 757.55 |
| Revenue From Operations / Share (Rs.) | 0.29 | 2.56 | 33.95 |
| PBDIT / Share (Rs.) | 3.88 | 0.04 | 0.22 |
| PBIT / Share (Rs.) | 3.88 | 0.04 | 0.19 |
| PBT / Share (Rs.) | 3.88 | 0.04 | 0.19 |
| Net Profit / Share (Rs.) | 3.31 | 0.03 | 0.11 |
| NP After MI And SOA / Share (Rs.) | 3.31 | 0.03 | 0.11 |
| PBDIT Margin (%) | 1320.40 | 1.84 | 0.66 |
| PBIT Margin (%) | 1320.40 | 1.84 | 0.56 |
| PBT Margin (%) | 1320.40 | 1.84 | 0.56 |
| Net Profit Margin (%) | 1125.53 | 1.39 | 0.34 |
| NP After MI And SOA Margin (%) | 1125.53 | 1.39 | 0.34 |
| Return on Networth / Equity (%) | 11.12 | 0.32 | 0.01 |
| Return on Capital Employeed (%) | 12.50 | 0.42 | 0.02 |
| Return On Assets (%) | 9.49 | 0.26 | 0.01 |
| Long Term Debt / Equity (X) | 0.02 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.02 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.00 | 0.20 | 0.00 |
| Current Ratio (X) | 3.40 | 4.69 | 3112.46 |
| Quick Ratio (X) | 1.66 | 2.79 | 1349.68 |
| Enterprise Value (Cr.) | 308.25 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 551.24 | 0.00 | 0.00 |
| EV / EBITDA (X) | 41.75 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 554.80 | 0.00 | 0.00 |
| Price / BV (X) | 5.48 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 555.10 | 0.00 | 0.00 |
| EarningsYield | 0.02 | 0.00 | 0.00 |
After reviewing the key financial ratios for Balgopal Commercial Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.70. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 15) to 3.70, marking an increase of 3.66.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.52. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 15) to 3.52, marking an increase of 3.48.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.31. This value is within the healthy range. It has increased from 0.03 (Mar 15) to 3.31, marking an increase of 3.28.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.77. It has increased from 10.99 (Mar 15) to 29.77, marking an increase of 18.78.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.77. It has increased from 10.99 (Mar 15) to 29.77, marking an increase of 18.78.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.29. It has decreased from 2.56 (Mar 15) to 0.29, marking a decrease of 2.27.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.88. This value is within the healthy range. It has increased from 0.04 (Mar 15) to 3.88, marking an increase of 3.84.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.88. This value is within the healthy range. It has increased from 0.04 (Mar 15) to 3.88, marking an increase of 3.84.
- For PBT / Share (Rs.), as of Mar 25, the value is 3.88. This value is within the healthy range. It has increased from 0.04 (Mar 15) to 3.88, marking an increase of 3.84.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.31. This value is within the healthy range. It has increased from 0.03 (Mar 15) to 3.31, marking an increase of 3.28.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.31. This value is within the healthy range. It has increased from 0.03 (Mar 15) to 3.31, marking an increase of 3.28.
- For PBDIT Margin (%), as of Mar 25, the value is 1,320.40. This value is within the healthy range. It has increased from 1.84 (Mar 15) to 1,320.40, marking an increase of 1,318.56.
- For PBIT Margin (%), as of Mar 25, the value is 1,320.40. This value exceeds the healthy maximum of 20. It has increased from 1.84 (Mar 15) to 1,320.40, marking an increase of 1,318.56.
- For PBT Margin (%), as of Mar 25, the value is 1,320.40. This value is within the healthy range. It has increased from 1.84 (Mar 15) to 1,320.40, marking an increase of 1,318.56.
- For Net Profit Margin (%), as of Mar 25, the value is 1,125.53. This value exceeds the healthy maximum of 10. It has increased from 1.39 (Mar 15) to 1,125.53, marking an increase of 1,124.14.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1,125.53. This value exceeds the healthy maximum of 20. It has increased from 1.39 (Mar 15) to 1,125.53, marking an increase of 1,124.14.
- For Return on Networth / Equity (%), as of Mar 25, the value is 11.12. This value is below the healthy minimum of 15. It has increased from 0.32 (Mar 15) to 11.12, marking an increase of 10.80.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.50. This value is within the healthy range. It has increased from 0.42 (Mar 15) to 12.50, marking an increase of 12.08.
- For Return On Assets (%), as of Mar 25, the value is 9.49. This value is within the healthy range. It has increased from 0.26 (Mar 15) to 9.49, marking an increase of 9.23.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 15) to 0.02, marking an increase of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from 0.00 (Mar 15) to 0.02, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. It has decreased from 0.20 (Mar 15) to 0.00, marking a decrease of 0.20.
- For Current Ratio (X), as of Mar 25, the value is 3.40. This value exceeds the healthy maximum of 3. It has decreased from 4.69 (Mar 15) to 3.40, marking a decrease of 1.29.
- For Quick Ratio (X), as of Mar 25, the value is 1.66. This value is within the healthy range. It has decreased from 2.79 (Mar 15) to 1.66, marking a decrease of 1.13.
- For Enterprise Value (Cr.), as of Mar 25, the value is 308.25. It has increased from 0.00 (Mar 15) to 308.25, marking an increase of 308.25.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 551.24. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 15) to 551.24, marking an increase of 551.24.
- For EV / EBITDA (X), as of Mar 25, the value is 41.75. This value exceeds the healthy maximum of 15. It has increased from 0.00 (Mar 15) to 41.75, marking an increase of 41.75.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 554.80. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 15) to 554.80, marking an increase of 554.80.
- For Price / BV (X), as of Mar 25, the value is 5.48. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 15) to 5.48, marking an increase of 5.48.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 555.10. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 15) to 555.10, marking an increase of 555.10.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 15) to 0.02, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balgopal Commercial Ltd:
- Net Profit Margin: 1125.53%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.5% (Industry Average ROCE: 15.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 11.12% (Industry Average ROE: 9.23%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.66
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 106 (Industry average Stock P/E: 103.57)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1125.53%
About the Company - Qualitative Analysis
Balgopal Commercial Ltd. is a Public Limited Listed company incorporated on 20/08/1982 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L51109MH1982PLC368610 and registration number is 035193. Currently Company is involved in the business activities of Wholesale of other clothing items. Company's Total Operating Revenue is Rs. 0.56 Cr. and Equity Capital is Rs. 19.01 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | Flat No. B-002, Dreamax Vega, Upadhyay Compound, Pump House, Mumbai Maharashtra 400093 | info@bcommercial.org http://www.bcommercial.org |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vijay Laltaprasad Yadav | Managing Director |
| Mr. Yash Saraogi | Non Executive Director |
| Mrs. Shrena Kalpesh Shah | Ind. Non-Executive Director |
| Ms. Shailesh Becharbhai Patel | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Balgopal Commercial Ltd?
Balgopal Commercial Ltd's intrinsic value (as of 10 October 2025) is 324.78 which is 40.60% higher the current market price of 231.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹439 Cr. market cap, FY2025-2026 high/low of 273/52.8, reserves of ₹37.65 Cr, and liabilities of 64.47 Cr.
What is the Market Cap of Balgopal Commercial Ltd?
The Market Cap of Balgopal Commercial Ltd is 439 Cr..
What is the current Stock Price of Balgopal Commercial Ltd as on 10 October 2025?
The current stock price of Balgopal Commercial Ltd as on 10 October 2025 is 231.
What is the High / Low of Balgopal Commercial Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Balgopal Commercial Ltd stocks is 273/52.8.
What is the Stock P/E of Balgopal Commercial Ltd?
The Stock P/E of Balgopal Commercial Ltd is 106.
What is the Book Value of Balgopal Commercial Ltd?
The Book Value of Balgopal Commercial Ltd is 29.8.
What is the Dividend Yield of Balgopal Commercial Ltd?
The Dividend Yield of Balgopal Commercial Ltd is 0.00 %.
What is the ROCE of Balgopal Commercial Ltd?
The ROCE of Balgopal Commercial Ltd is 14.8 %.
What is the ROE of Balgopal Commercial Ltd?
The ROE of Balgopal Commercial Ltd is 12.6 %.
What is the Face Value of Balgopal Commercial Ltd?
The Face Value of Balgopal Commercial Ltd is 10.0.